Congratulations to the finalists of the 2024 Fierce CRO Awards!
Entries were judged on the ability of the applicant to demonstrate the following: innovation and impact, measurable outcomes, sustainability and scalability, and ethical and regulatory adherence.
The winners will be announced in the CRO Report on Monday, December 9, which will feature spotlights and interviews of all category winners.
CRO Champion Award
Emmes Group: Dr. Jose Jimeno, Chief Medical Officer, Emmes Group
IQVIA Technologies: One Home for Sites team from IQVIA Technologies
Excellence in Client Service and Partnership
Crown Bioscience: Crown Bioscience #1CX Delivering Excellence with Impact
ICON
Quotient Sciences: Quotient Sciences: Excellence in Client Service and Partnership
Excellence in Clinical Trial Management
Beaufort CRO
CBCC Global Research: CBCC Global Research - CRO
Novotech
Excellence in Global Operations
CBCC Global Research: CBCC Global Research - CRO - Global Operations
Novotech
Innovative Approaches to Patient-Centric Research
ICON, plc.: ICON Global Patient Insights
MediMergent, LLC
Parexel
Innovative Solutions in Drug Development
CrystalsFirst GmbH: MAGNET Platform
Emmes Group: Veridix AI: GlobalTrace
Quotient Sciences: Quotient Sciences: Innovative Solutions in Drug Development
WuXi Biologics: WuXi Biologics T Cell Mate Platform
Leadership in Regulatory Compliance
ProPharma: Matthew Weinberg
CMIC Group
MMS: MMS Regulatory Team
Outstanding Patient Recruitment and Retention
CTI Clinical Trial & Consulting: Innovative Patient Recruitment Strategies in the Bexion Trial
Emmes Group: VaxTRIALS part of Emmes Group
Lindus Health